Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 2,990.7 | 2,704.6 | 2,772.1 | 2,665.9 | 2,498.2 |
Revenue growth | 10.6% | -2.4% | 4.0% | 6.7% | |
Cost of goods sold | 1,657.6 | 1,516.5 | 1,581.3 | 1,530.8 | 1,425.4 |
Gross profit | 1,333.1 | 1,188.1 | 1,190.8 | 1,135.1 | 1,072.8 |
Gross margin | 44.6% | 43.9% | 43.0% | 42.6% | 42.9% |
Selling, general and administrative | 621.6 | 508.4 | 491.3 | 499.3 | 445.8 |
Research and development | 129.3 | 126.2 | 136.4 | 136.2 | 126.2 |
EBITA | 637.7 | 587.4 | 601.1 | 532.7 | 500.8 |
EBITA margin | 21.3% | 21.7% | 21.7% | 20.0% | 20.0% |
Amortization of intangibles | 42.4 | 29.0 | 31.8 | 30.6 | |
EBIT | 595.3 | 558.4 | 569.3 | 502.1 | 500.8 |
EBIT margin | 19.9% | 20.6% | 20.5% | 18.8% | 20.0% |
Pre-tax income | 534.0 | 460.3 | 565.8 | 507.3 | 523.9 |
Income taxes | 121.0 | 118.3 | 129.3 | 121.8 | 150.6 |
Tax rate | 22.7% | 25.7% | 22.9% | 24.0% | 28.7% |
Net income | 413.0 | 342.0 | 436.5 | 385.5 | 373.3 |
Net margin | 13.8% | 12.6% | 15.7% | 14.5% | 14.9% |
|
Diluted EPS | $2.43 | $2.02 | $2.59 | $2.29 | |
Shares outstanding (diluted) | 170.1 | 169.4 | 168.4 | 168.4 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|